Goldman Sachs
GRCL

Goldman Sachs’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Goldman Sachs’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
2023
Q4 		$182K Buy
2023
Q3 		$46K Sell
2023
Q2 		$65.7K Sell
2023
Q1 		$32.5K Sell
2022
Q4 		$47.1K Sell
2022
Q3 		$75K Sell
2022
Q2 		$134K Sell
2022
Q1 		$243K Buy
2021
Q4 		$108K Buy